Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
John Paul Clancy, MD |
CFF-TDN site |
Cystic Fibrosis Fdn Therapeutics, Inc |
AMIN09Y0/CLANCY14Y0 |
01/01/2013 - 12/31/2017 |
$112,468 |
Jason C Woods, PhD |
Severe Asthma Research Program |
National Institutes of Health (Washington University) |
U10 HL109257 |
02/01/2013 - 05/31/2017 |
$8,547 |
Michael Seid, PhD |
FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes |
National Institutes of Health (University of North Carolina) |
UC4 DK101132 |
09/15/2013 - 06/30/2018 |
$600,736 |
Anjaparavanda Naren, PhD |
Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea |
National Institutes of Health |
R01 DK080834 |
09/18/2013 - 03/31/2018 |
$333,313 |
Anjaparavanda Naren, PhD |
Characterization of an Inhibitory Protein Complex for Cystic Fibrosis Therapy |
National Institutes of Health (Univ of Tennessee Health Science Center) |
R01 HL123535 |
08/15/2014 - 06/30/2019 |
$17,539 |
Gary McPhail, MD |
Cystic Fibrosis Center Program Accreditation And Funding |
Cystic Fibrosis Foundation |
CC160-130 |
07/01/2013 - 06/30/2018 |
$150,270 |
Michael Seid, PhD |
Measures of Hypoglycemia and Glycemic Variability Using Continuous Glucose Monitoring in the FL3X Intervention for Youth With Type 1 Diabetes |
The Leona M & Harry B Helmsley Charitabl (University of North Carolina) |
2014PG-T1D030 |
01/01/2014 - 12/31/2017 |
$8,100 |
John Paul Clancy, MD |
Pilot Development of Translational Primary Human Airway Model Systems to Advance CF Care |
Cystic Fibrosis Foundation |
CLANCY14XX0 |
07/01/2014 - 06/30/2018 |
$95,794 |
Anjaparavanda Naren, PhD |
CF-Patient Specific Enteroids from Small Intestine and Colon |
Cystic Fibrosis Fdn Therapeutics, Inc |
NAREN14XX0 |
07/01/2014 - 06/30/2018 |
$226,708 |
Jason C Woods, PhD |
Molecular Pathogenesis and Treatment of Pulmonary Alveolar Microlithiasis |
National Institutes of Health (University of Cincinnati) |
R01 HL127455 |
04/01/2015 - 03/31/2020 |
$36,075 |
John Paul Clancy, MD |
PROSPECT |
Cystic Fibrosis Fdn Therapeutics, Inc |
CLANCY14K1 |
07/01/2014 - 06/30/2019 |
$37,047 |
Anjaparavanda Naren, PhD |
LPA2 Receptor-containing Complexes in Regulating Secretory Diarrhea |
National Institutes of Health |
R01 DK093045 |
07/01/2015 - 06/30/2020 |
$351,000 |
Sara M Zak, MD |
First/Second Year Clinical Fellowship Grant Application |
Cystic Fibrosis Foundation |
ZAK15B0 |
07/01/2015 - 06/30/2017 |
$66,250 |
Raouf Samy Amin, MD |
Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC |
National Institutes of Health (Children's Hospital of Philadelphia) |
U01 HL125295 |
09/04/2015 - 10/31/2016 |
$239,150 |
John Paul Clancy, MD |
TDC ARC Award |
Cystic Fibrosis Fdn Therapeutics, Inc |
CLANCY14Y4 |
12/01/2014 - 11/30/2018 |
$32,694 |
Zackary Cleveland, PhD |
Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury |
National Institutes of Health |
R00 HL111217 |
08/15/2015 - 07/31/2018 |
$242,816 |
William Hardie, MD
John Paul Clancy, MD |
Cincinnati Children's Summer Medical Student Respiratory Research Fellowship |
National Institutes of Health |
T35 HL113229 |
05/01/2016 - 04/30/2021 |
$68,526 |
John Paul Clancy, MD |
Personalizing Cystic Fibrosis Research Translation |
Cystic Fibrosis Foundation |
CLANCY15R0 |
07/01/2015 - 06/30/2019 |
$470,000 |
Gary McPhail, MD |
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis |
Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) |
PROSPECT-OB-14 |
02/23/2015 - 02/22/2018 |
$83,492 |
John Paul Clancy, MD |
SHIP (Saline Hypertonic in Preschoolers) Study - Planning Grant |
Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) |
SHIP14K0 |
11/01/2014 - 10/31/2018 |
$34,625 |
Daniel Grossoehme, D.Min. |
Training Research-Literate Chaplains as Ambassadors for Spirituality and Health: Phase I |
John Templeton Foundation (Rush Medical University Center) |
51996 |
07/01/2015 - 06/30/2019 |
$8,826 |
Jason C Woods, PhD
John Paul Clancy, MD |
UTE MRI to Monitor CF Lung Disease and Response to CFTR Modulation in Young Children |
National Institutes of Health |
R01 HL131012 |
05/01/2016 - 03/31/2021 |
$745,633 |
Anjaparavanda Naren, PhD |
Human Small Intestinal Model from CF-Patients using Pluripotent Stem Cells |
Cystic Fibrosis Foundation |
NAREN16I0 |
04/01/2016 - 03/31/2018 |
$54,000 |
John J Brewington, MD |
Sensitivity of Corrected F508del CFTR to Chronic beta-agonist Therapy |
Cystic Fibrosis Foundation |
BREWIN16A0 |
07/01/2016 - 06/30/2019 |
$130,000 |
Zackary Cleveland, PhD |
Regional Biomarkers of Peripheral Lung Disease in Cystic Fibrosis |
Cystic Fibrosis Fdn Therapeutics, Inc |
CLEVEL16A0 |
04/01/2016 - 03/31/2019 |
$108,000 |
Anjaparavanda Naren, PhD |
Transporters and Hematopoietic Toxicity |
National Institutes of Health (St Jude's Children's Hospital) |
R01 CA194206 |
07/01/2016 - 06/30/2021 |
$23,595 |
Satish K Madala, PhD
Anil Goud Jegga, DVM |
Integrative Analysis of Multi-omics Data to Target Fibroblast Activation in IPF |
National Institutes of Health |
R21 HL133539 |
07/05/2016 - 06/30/2018 |
$63,929.50 |
Michael Seid, PhD |
A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System |
Cystic Fibrosis Fdn Therapeutics, Inc |
SEID15A0 |
01/01/2016 - 12/31/2018 |
$1,542,986 |
Satish K Madala, PhD |
WT1 Regulation of Pulmonary Fibrosis |
National Institutes of Health |
R01 HL134801 |
05/22/2017 - 04/30/2022 |
$409,242 |
John Paul Clancy, MD |
CFFT Biomarker Consortium |
Cystic Fibrosis Fdn Therapeutics, Inc |
CLANCY11CS0 |
01/01/2016 - 12/31/2017 |
$23,230 |
Assem Ziady, PhD |
Manipulating Vector Interactome to Enhance Gene Transfer in Cystic Fibrosis |
Cystic Fibrosis Foundation |
ZIADY1610 |
11/01/2016 - 10/31/2018 |
$54,000 |
Christopher Siracusa, MD |
CFF Success with Therapies Research Consortium |
Cystic Fibrosis Fdn Therapeutics, Inc |
SIRACU15PE0 |
08/01/2016 - 07/31/2018 |
$27,000 |
Geoffrey Walter Rulong, MD |
Custom 3-D Printed Non-invasive Ventilation Mask |
American Sleep Medicine Foundation |
160-FP-17 |
02/14/2017 - 02/13/2018 |
$19,377 |
Raouf Samy Amin, MD |
Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC |
National Institutes of Health (Children's Hospital of Philadelphia) |
U01 HL125295 |
07/01/2016 - 06/30/2020 |
$250,723 |
Christopher Siracusa, MD |
DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF |
Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hospital Boston) |
CHB - Siracusa,Chris |
01/01/2017 - 12/31/2017 |
$4,190 |
Theresa Guilbert, MD, MS |
Controlling and Preventing Asthma Progression and Severity in Kids (CASK) |
National Institutes of Health (Children's Hospital Boston) |
U01 AI126614 |
04/01/2017 - 06/30/2017 |
$50,000 |
Total Annual Grant Award Dollars |
$6,729,881.50 |